Article

CMS Expects Medicare Prescription Premiums to Rise

Medicare prescription drug premiums are expected to increase next year, according to CMS projections issued Monday.

The average monthly premium for basic prescription drug coverage is expected to rise to $30 from the $29.67 average this year, according to bids submitted by drug and health plans.

Read the full story: http://tinyurl.com/8n9umqr

Source: ModernHealthcare.com

The small increase reverses the small drop from last year when the average drug plan premium was $30.76. At the time, CMS officials credited a number of efforts for the drop, including an increased use of generic medications.

Related Videos
Casey Koch, PharmD, sitting for a video interview
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Kimlin Tam Ashing
Jaime Almandoz, MD, MBA
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Dr Johnie Rose
Related Content
Pharmacy Panel at Asembia ASX25 | Image credit: Pearl Steinzor
April 29th 2025

Pharmacy Leaders Discuss Innovation and Patient-Centered Care at Asembia’s AXS25 Summit

Pearl Steinzor
At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and navigate a shifting health care environment.
managed care cast logo
April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
The Senate | Image credit: MoiraM - stock.adobe.com
April 29th 2025

Trump’s First 100 Days: Workforce Cuts, Drug Pricing, and Medicaid Reform

Pearl Steinzor
Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Affordable Care Act | Image credit: Vitalii Vodolazskyi - stock.adobe.com
April 25th 2025

5 Challenges the Affordable Care Act Overcame in the Last 15 Years

Giuliana Grossi
As the Affordable Care Act passed its 15th anniversary this year, Supreme Court Justices continue to deliberate the fate of its preventive services mandate in Kennedy v Braidwood.
glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com
April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo